Alexander Tung Email & Phone Number

Alexander Tung Work

• Vice President Quality Assurance @ AN2 Therapeutics (May 2022 - Present)
  View Department
• Sr. Director, Quality Assurance @ Retrotope, Inc. (May 2021 - May 2022)
• Sr. Director, Quality Assurance @ Quark Pharmaceuticals, Inc. (March 2020 - April 2021)
• Sr. Director, Quality Assurance @ Symic Bio, Inc. (June 2017 - December 2019)
• Associate Director, Quality Assurance @ XOMA (US) LLC (July 2015 - December 2016)
• Consultant @ USDM Life Sciences (July 2014 - July 2015)
• Director, Quality Assurance @ Hyperion Therapeutics, Inc. (acquired by Horizon Pharma) (May 2013 - December 2013)
• Senior Manager, Quality Compliance @ Allergan, Inc. (acquired MAP Pharmaceuticals, Inc.) (November 2011 - April 2013)
• Manager, Compliance @ Gilead Sciences (July 2009 - November 2011)
• Senior Manager, Quality Assurance @ CV Therapeutics (acquired by Gilead Sciences, Inc.) (April 2009 - July 2009)
• Associate Director, QA Compliance @ Cell Genesys, Inc. (acquired by BioSante Pharmaceuticals) (July 2007 - November 2008)
• QA Project Manager @ Accucaps Industries Ltd. (acquired by Catalent, Inc.) (July 2005 - July 2007)
• Manager, QA-GMP Compliance @ ICOS Corporation (September 2003 - July 2005)
• Manager, Quality Assurance; Manager, QA Product Release; Manager, Documentation Control @ TorPharm, Inc. (April 2001 - August 2003)
• QA Manager, U.S. and Third Party Products @ Novopharm Limited (acquired by Teva Pharmaceutical Industries Ltd.) (January 2000 - April 2001)
• Manager, Corporate Audit; Supervisor, Quality Assurance @ Novopharm Limited (acquired by Teva Pharmaceutical Industries Ltd.) (February 1998 - December 1999)
• Quality Assurance Auditor @ Novopharm Limited (acquired by Teva Pharmaceutical Industries Ltd.) (January 1997 - January 1998)
• Raw Material Chemist @ Novopharm Limited (acquired by Teva Pharmaceutical Industries Ltd.) (January 1995 - December 1996)
• Laboratory Technologist @ SGS (March 1994 - December 1994)